Kingstown Capital - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 1 filers reported holding BIOTECH ACQUISITION COMPANY in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Kingstown Capital ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q3 2022$18,000
-33.3%
300,0000.0%0.06%
+31.1%
Q2 2022$27,000
-62.5%
300,0000.0%0.04%
-58.7%
Q1 2022$72,000
-63.6%
300,0000.0%0.11%
-56.2%
Q4 2021$198,0000.0%300,0000.0%0.25%
+25.8%
Q3 2021$198,000
-23.3%
300,0000.0%0.20%
+28.6%
Q2 2021$258,000
+72.0%
300,000
+20.0%
0.15%
+196.2%
Q1 2021$150,000250,0000.05%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q3 2023
NameSharesValueWeighting ↓
Kingstown Capital 300,000$72,0000.11%
Telemetry Investments, L.L.C. 153,694$36,0000.06%
Kamunting Street Capital Management, L.P. 158,962$38,0000.05%
Radcliffe Capital Management, L.P. 202,950$2,001,0000.04%
Q Global Advisors, LLC 300,000$72,0000.04%
Integrity Capital Management (HK) Ltd 33,267$8,0000.04%
Corbin Capital Partners, L.P. 464,062$111,0000.02%
HGC Investment Management Inc. 1,215,782$292,0000.02%
Segantii Capital Management Ltd 50,000$493,0000.01%
Sage Rock Capital Management LP 286,900$69,0000.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders